8Boehme MW, Raeth U, Galle PR, et al. Serum thrombomodulin-a reliable marker of disease activity in systemic lupus erythmatosus (SEE): advantage over established serological parameters to indicate disease activity. Clin Exp Immunol, 2000, 119: 189-195.
9Junzo N, Hirohiko K, Etsuji S, et al. Anti-prothrombin antibodies combined with lupus anticoagulant activity is an essential risk factor for venous thromboembolism in patients with systemic lupus erythematosus. Br J Haemato, 2001, 114: 647-654.
10Frijns CJM, Derksen HWM, de Groot G, et al. Lupus anticoagulant and history of thrombosis are not associated with persistent endothelial cell activation in systemic lupus erythematosus. Clin Exp Immunol, 2001, 125: 149-154.
